6577 POSTER Investigating Potential Biomarkers for Survival With Erlotinib in Patients With Advanced Pancreatic Cancer – Results of the Phase II B021129 Study

MLA

Barbara Klughammer, et al. “6577 POSTER Investigating Potential Biomarkers for Survival With Erlotinib in Patients With Advanced Pancreatic Cancer – Results of the Phase II B021129 Study.” European Journal of Cancer, vol. 47, Sept. 2011, p. S464. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........7e1bf4873c695d672f650e66eceea4c9&authtype=sso&custid=ns315887.

APA

Barbara Klughammer, Michel Ducreux, I. Davidenko, T. van der Horst, Limas Kupčinskas, John Bridgewater, H. Johannsdottir, & David Propper. (2011). 6577 POSTER Investigating Potential Biomarkers for Survival With Erlotinib in Patients With Advanced Pancreatic Cancer – Results of the Phase II B021129 Study. European Journal of Cancer, 47, S464.

Chicago

Barbara Klughammer, Michel Ducreux, I. Davidenko, T. van der Horst, Limas Kupčinskas, John Bridgewater, H. Johannsdottir, and David Propper. 2011. “6577 POSTER Investigating Potential Biomarkers for Survival With Erlotinib in Patients With Advanced Pancreatic Cancer – Results of the Phase II B021129 Study.” European Journal of Cancer 47 (September): S464. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........7e1bf4873c695d672f650e66eceea4c9&authtype=sso&custid=ns315887.